STAT Plus: FDA approves the first treatment for peanut allergy, but commercial success is hardly assured
Children and teenagers with severe, sometimes life-threatening peanut allergies can reduce their risk from accidental exposure with a new treatment approved Friday by the Food and Drug Administration.
But administering the new treatment, called Palforzia and made by Aimmune Therapeutics (AIMT), is cumbersome and carries its own safety risks, which may deter families and allergists from using it.
Continue to STAT Plus to read the full story…
